John Milligan, Gilead’s new CEO, will face many challenges, including pressures over competition and pricing for the company’s hepatitis C pills. Gilead sales have risen nearly 3½ times to $32.2 billion last year.

Topics:  john milligan   gilead s   ceo   c   pressures   

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News